Retirement Group’s Oncolytics Biotech ONCY Stock Holding History

Retirement Group’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$5K	Buy	+1,000	New	+$1.13K	﹤0.01%	457

Other funds holding ONCY

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Retirement Group's ONCY Position: Q4 2019 in Review

Retirement Group opened a new position in Oncolytics Biotech (ONCY) in Q4 2019: 1,000 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #457 among its holdings.

28 funds tracked by Wall St. Rank hold ONCY as of Q4 2019.

Retirement Group held 1,000 shares of Oncolytics Biotech worth $5K as of Q4 2019.
Oncolytics Biotech was a new Retirement Group position in Q4 2019.
Oncolytics Biotech made up ﹤0.01% of Retirement Group's portfolio in Q4 2019, its #457 holding.
28 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q4 2019.

Based on Retirement Group's 13F filing for Q4 2019, filed 30 Aug 2021.